Bio-Techne Corp at Nasdaq London Investor Conference Transcript - Thomson StreetEvents

Bio-Techne Corp at Nasdaq London Investor Conference Transcript

Bio-Techne Corp at Nasdaq London Investor Conference Transcript - Thomson StreetEvents
Bio-Techne Corp at Nasdaq London Investor Conference Transcript
Published Dec 09, 2025
8 pages (5033 words) — Published Dec 09, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of TECH.OQ presentation 9-Dec-25 9:30am GMT

  
Brief Excerpt:

...All right. I guess the music is off, and that is our queue. So thank you all for joining us today for our conversation. We'll kick things off, and then you'll do most of talking to tell this incredible story for us. But for everybody, I'm Jack Cassel, Senior Vice President with Nasdaq. And I'm excited for our discussion today with the Chief Executive Officer, Kim Kelderman; and Chief Financial Officer, Jim Hippel, for Bio-Techne. So maybe for the audience, let's level set with just an overview on the business. Kim Kelderman ...

  
Report Type:

Transcript

Source:
Company:
Bio-Techne Corp
Ticker
TECH.OQ
Time
9:30am GMT
Format:
PDF Adobe Acrobat
Buy Now

Bio-Techne Corp at Nasdaq London Investor Conference Summary – 2025-12-09 – US$ 54.00 – Edited Brief of TECH.OQ presentation 9-Dec-25 9:30am GMT

Bio-Techne Corp at Citi Global Healthcare Conference Summary – 2025-12-03 – US$ 54.00 – Edited Brief of TECH.OQ presentation 3-Dec-25 8:15pm GMT

Bio-Techne Corp at Citi Global Healthcare Conference Transcript – 2025-12-03 – US$ 54.00 – Edited Transcript of TECH.OQ presentation 3-Dec-25 8:15pm GMT

Bio-Techne Corp at Evercore ISI Healthcare Conference Summary – 2025-12-02 – US$ 54.00 – Edited Brief of TECH.OQ presentation 2-Dec-25 1:20pm GMT

Bio-Techne Corp at Evercore ISI Healthcare Conference Transcript – 2025-12-02 – US$ 54.00 – Edited Transcript of TECH.OQ presentation 2-Dec-25 1:20pm GMT

Bio-Techne Corp at Jefferies Global Healthcare Conference Summary – 2025-11-20 – US$ 54.00 – Edited Brief of TECH.OQ presentation 20-Nov-25 12:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Bio-Techne Corp at Nasdaq London Investor Conference Transcript" Dec 09, 2025. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Bio-Techne-Corp-at-Nasdaq-London-Investor-Conference-T16589015>
  
APA:
Thomson StreetEvents. (2025). Bio-Techne Corp at Nasdaq London Investor Conference Transcript Dec 09, 2025. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Bio-Techne-Corp-at-Nasdaq-London-Investor-Conference-T16589015>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.